(Q44809855)

6 December 2017

title

Mass screening for neuroblastoma at 6 months of age: difficult to justify (English)

1 reference

6 December 2017

1 reference

Suita S

1

1 reference

6 December 2017

Tajiri T

2

1 reference

6 December 2017

Akazawa K

3

1 reference

6 December 2017

Sera Y

4

1 reference

6 December 2017

Takamatsu H

5

1 reference

6 December 2017

Mizote H

6

1 reference

6 December 2017

Ohgami H

7

1 reference

6 December 2017

Kurosaki N

8

1 reference

6 December 2017

Hara T

9

1 reference

6 December 2017

Okamura J

10

1 reference

6 December 2017

Miyazaki S

11

1 reference

6 December 2017

Sugimoto T

12

1 reference

6 December 2017

Kawakami K

13

1 reference

6 December 2017

Tsuneyoshi M

14

1 reference

6 December 2017

Tasaka H

15

1 reference

6 December 2017

Yano H

16

1 reference

6 December 2017

Akiyama H

17

1 reference

6 December 2017

Ikeda K

18

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

Journal of Pediatric Surgery

6 December 2017

published in

1 reference

6 December 2017

volume

33

1 reference

6 December 2017

issue

11

1 reference

6 December 2017

page(s)

1674-1678

1 reference

Neuroblastoma. Mass screening for early detection and its prognosis

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

How to deal with advanced cases of neuroblastoma detected by mass screening: a report from the Pediatric Oncology Study Group of the Kyushu area of Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Mass screening for neuroblastoma and mortality in birth cohorts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

A population-based study of the usefulness of screening for neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

[The "Lower Saxony/Northern Rhine-Westphalia" Neuroblastoma Screening Project: on the need for epidemiologic comparison]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Mass-screening of neuroblastoma using urine from infants by high-performance liquid chromatographic method: results of first (6th month) and second (14th month) screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

Natural history of neuroblastoma found by mass screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3468%2898%2990607-8

10.1016/S0022-3468(98)90607-8

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference